Phase I study of docetaxel with concomitant thoracic radiation therapy

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 159-164

  Mauer, Ann M ^a   Masters, Gregory A ^a   Haraf, Daniel J ^a   Hoffman, Philip C ^a   Watson, Sylvia M ^a   Golomb, Harvey M ^a   Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS STRICTURE; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFILTRATE; LUNG NON SMALL CELL CANCER; MALE; MAXIMUM PERMISSIBLE DOSE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031972580     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.159     Document Type: Article

References (25)

1. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990
2. Ginsberg RJ, Vokes EE, Raben A: Non-small cell lung cancer, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott, 1996, pp 858-911
3. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940-945, 1990
4. Le Chevalier T, Arriagada R, Tarayre M, et al: Significant effect of adjuvant chemotherapy on survival in locally-advanced non-small cell lung carcinoma. J Natl Cancer Inst 84:58, 1992
5. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung carcinoma: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991
6. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588. Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
7. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524-530, 1992
8. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized trials. Br Med J 311:899-909, 1995
9. Herskovic A, Martz K, Al-Sarraf, M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598, 1992
10. Al-Sarraf, Martz K, Herskovic L, et al: Progress report of combined chemoradiotherapy versus radiotherapy alone inpatients with esophageal cancer: An intergroup study. J Clin Oncol 15:277-284, 1997
11. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
12. Tishler RB, Schiff PB, Geard CR, et al. Taxol: A novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22:613-617, 1992
13. Choy H, Rodriguez F, Koester S, et al: Investigation of Taxol as a potential radiation sensitizer. Cancer 71:3774-3778, 1993
14. Steern A, Sevin BU, Ferras J, et al: Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 48:252-258, 1993
15. Choy H, Rodriguez F, Koester S, et al: Synergistic effects of taxol/taxotere on radiation sensitivity on human tumor cell lines. Int J Radiat Oncol Biol Phys 24:274-275, 1993 (suppl 1)
16. Burris H, Irvin R, Kuhn J, et al: Phase I clinical trial of Taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol 11:950-958, 1993
17. Tomiak E, Piccart MJ, Kerger J: A phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis. J Clin Oncol 12:1458-1467, 1994
18. Francis PA, Rigas JR, Kris MG, et al: Phase II trial of docetaxel in patients with stage III and IV non-small cell lung cancer. J Clin Oncol 12:1232-1237, 1994
19. 2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer. Cancer 75:968-972, 1995
20. Fossella FV, Lee JS, Murphy WK, et al: Phase II study of docetaxel for recurrent of metastatic non-small cell lung cancer. J Clin Oncol 12:1238-1244, 1994
21. Ajani JA, Ilson DH, Daugherty K, et al: Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086-1091, 1994
22. Choy H, Akerley W, Safran H, et al: Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 12:2682-2686, 1994
23. Hudes R, Langer C, Movsas B, et al: Induction paclitaxel (Taxol) and carboplatin (CBDCA) followed by concurrent chemoradiotherapy (TRT-CT) in unresectable, locally advanced non-small lung carcinoma (NSCLC): Report of FCCC 94-001. Proc Am Soc Clin Oncol 16:448a, 1997 (abstr 1609)
24. Reckzeh B, Merte H, Pfluger KH, et al: Severe lymphopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol 14:1071-1076, 1996
25. Mackall CL, Fleisher TA, Brown MR, et al: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221-2228, 1994